Cargando…

A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia

Patient: Male, 77-year-old Final Diagnosis: Heparin induced aldosterone suppression • heparin induced hyperkalemia Symptoms: Cough • dyspnea Medication: — Clinical Procedure: — Specialty: Cardiology • Endocrinology and Metabolic • General and Internal Medicine • Nephrology OBJECTIVE: Unusual or unex...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovacs, Jonathan, Talib, Samer, Khashan, Abdallah, Garsondiya, Bhaveshkumar, Carson, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319301/
https://www.ncbi.nlm.nih.gov/pubmed/35859349
http://dx.doi.org/10.12659/AJCR.937017
_version_ 1784755516225880064
author Kovacs, Jonathan
Talib, Samer
Khashan, Abdallah
Garsondiya, Bhaveshkumar
Carson, Michael P.
author_facet Kovacs, Jonathan
Talib, Samer
Khashan, Abdallah
Garsondiya, Bhaveshkumar
Carson, Michael P.
author_sort Kovacs, Jonathan
collection PubMed
description Patient: Male, 77-year-old Final Diagnosis: Heparin induced aldosterone suppression • heparin induced hyperkalemia Symptoms: Cough • dyspnea Medication: — Clinical Procedure: — Specialty: Cardiology • Endocrinology and Metabolic • General and Internal Medicine • Nephrology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Anticoagulation with heparin infrequently causes elevated serum potassium via a reduction in the number and affinity of adrenal angiotensin II receptors, causing reversible aldosterone suppression, thereby leading to enhanced sodium excretion and hyperkalemia. CASE REPORT: A 77 year-old man presented with productive cough and shortness of breath and was subsequently found to have non-ST-elevation myocardial infarction and concomitant symptomatic COVID-19 infection, for which he was started on a high-dose unfractionated heparin infusion. A gradual increase in serum potassium followed, with a subsequent return to a normal potassium level after stopping treatment with heparin. An evaluation for hemolysis was unrevealing, and the patient was not on any other medications known to cause hyperkalemia. On day 6, heparin was restarted owing to a high suspicion of pulmonary embolism. There was a subsequent increase in serum potassium level, which was followed by a return to baseline after discontinuation of heparin, thereby confirming the suspected diagnosis. CONCLUSIONS: Acute increases in serum potassium levels in hospitalized patients can result in weakness, paralysis, conduction abnormalities, and cardiac arrhythmias that, if left untreated, can result in serious morbidity and potentially death in a short period of time. As this clinical entity is infrequently encountered in clinical practice, it can easily be overlooked by clinicians. The prompt exclusion of alternative causes of acutely elevated serum potassium levels and the identification of heparin administration as an easily reversible trigger is imperative and can potentially be life-saving.
format Online
Article
Text
id pubmed-9319301
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93193012022-08-03 A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia Kovacs, Jonathan Talib, Samer Khashan, Abdallah Garsondiya, Bhaveshkumar Carson, Michael P. Am J Case Rep Articles Patient: Male, 77-year-old Final Diagnosis: Heparin induced aldosterone suppression • heparin induced hyperkalemia Symptoms: Cough • dyspnea Medication: — Clinical Procedure: — Specialty: Cardiology • Endocrinology and Metabolic • General and Internal Medicine • Nephrology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Anticoagulation with heparin infrequently causes elevated serum potassium via a reduction in the number and affinity of adrenal angiotensin II receptors, causing reversible aldosterone suppression, thereby leading to enhanced sodium excretion and hyperkalemia. CASE REPORT: A 77 year-old man presented with productive cough and shortness of breath and was subsequently found to have non-ST-elevation myocardial infarction and concomitant symptomatic COVID-19 infection, for which he was started on a high-dose unfractionated heparin infusion. A gradual increase in serum potassium followed, with a subsequent return to a normal potassium level after stopping treatment with heparin. An evaluation for hemolysis was unrevealing, and the patient was not on any other medications known to cause hyperkalemia. On day 6, heparin was restarted owing to a high suspicion of pulmonary embolism. There was a subsequent increase in serum potassium level, which was followed by a return to baseline after discontinuation of heparin, thereby confirming the suspected diagnosis. CONCLUSIONS: Acute increases in serum potassium levels in hospitalized patients can result in weakness, paralysis, conduction abnormalities, and cardiac arrhythmias that, if left untreated, can result in serious morbidity and potentially death in a short period of time. As this clinical entity is infrequently encountered in clinical practice, it can easily be overlooked by clinicians. The prompt exclusion of alternative causes of acutely elevated serum potassium levels and the identification of heparin administration as an easily reversible trigger is imperative and can potentially be life-saving. International Scientific Literature, Inc. 2022-07-21 /pmc/articles/PMC9319301/ /pubmed/35859349 http://dx.doi.org/10.12659/AJCR.937017 Text en © Am J Case Rep, 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Kovacs, Jonathan
Talib, Samer
Khashan, Abdallah
Garsondiya, Bhaveshkumar
Carson, Michael P.
A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia
title A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia
title_full A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia
title_fullStr A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia
title_full_unstemmed A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia
title_short A 77-Year-Old Man with Heparin-Induced Aldosterone Suppression Causing Hyperkalemia
title_sort 77-year-old man with heparin-induced aldosterone suppression causing hyperkalemia
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319301/
https://www.ncbi.nlm.nih.gov/pubmed/35859349
http://dx.doi.org/10.12659/AJCR.937017
work_keys_str_mv AT kovacsjonathan a77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT talibsamer a77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT khashanabdallah a77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT garsondiyabhaveshkumar a77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT carsonmichaelp a77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT kovacsjonathan 77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT talibsamer 77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT khashanabdallah 77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT garsondiyabhaveshkumar 77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia
AT carsonmichaelp 77yearoldmanwithheparininducedaldosteronesuppressioncausinghyperkalemia